New results from a subgroup analysis of the ICONIC-LEAD study showed icotrokinra was effective and safe for the treatment of moderate to severe plaque psoriasis in adolescents, according to a press ...

Icotrokinra is efficacious and safe for treating moderate to severe plaque psoriasis among adolescents and adults when compared with placebo.

Psoriasis shows on the skin, but it's a disease which goes a lot deeper and is linked to serious health problems. In recent years, newer targeted drugs are making a difference.

Deucravacitinib has been observed as a safe and efficacious treatment for adults with moderate to severe plaque psoriasis for up to 4 years.

A panelist discusses how real-world evidence from a large cohort study (n = 31521) presented at AAD 2025 reveals notable ...

A RECENT study has highlighted key biological and clinical factors linked to resistance to biologic therapies in patients ...

Researchers reported a shared genetic susceptibility of psoriasis and hidradenitis suppurativa, highlighting a need for ...

New data presented at the 2025 World Congress of Pediatric Dermatology annual meeting highlights the efficacy and safety of ...

Protagonist and Johnson & Johnson report positive Phase 3 data on icotrokinra in adolescent plaque psoriasis, showing high ...

Several characteristics, including BMI and Charlson Comorbidity Index, were associated with super response to biologics in patients with psoriasis.

Northwest Florida Democrats are turning out at higher rates than past years ahead of Tuesday’s special election, unofficial voter turnout numbers show. The biggest election on the ballot Tuesday ...

CAMBRIA COUNTY, Pa (WJAC) — In Cambria County, Richland Township officials say they're hoping the broken traffic signal on Scalp Avenue will be fixed soon, though they still do not have an exact ...